Skip to main content
SpringerLink
Log in

Estrogen + progestin linked to delayed risk of cancer

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SAA, Brzyski R, Chlebowski RT, Gass M, Lacroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML, WHI Investigators.Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA: the Journal of the American Medical Association 299: 1036-1045, No. 9, 5 Mar 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Estrogen + progestin linked to delayed risk of cancer. React. Wkly. 1193, 1 (2008). https://doi.org/10.2165/00128415-200811930-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811930-00001

Keywords

Search

Navigation